Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prenetics Global (PRE) Cost of Revenue (2021 - 2025)

Historic Cost of Revenue for Prenetics Global (PRE) over the last 5 years, with Q3 2025 value amounting to $9.5 million.

  • Prenetics Global's Cost of Revenue rose 49198.76% to $9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.2 million, marking a year-over-year increase of 37865.46%. This contributed to the annual value of $15.2 million for FY2024, which is 1787.35% up from last year.
  • Latest data reveals that Prenetics Global reported Cost of Revenue of $9.5 million as of Q3 2025, which was up 49198.76% from $10.4 million recorded in Q2 2025.
  • In the past 5 years, Prenetics Global's Cost of Revenue ranged from a high of $56.0 million in Q1 2022 and a low of $358000.0 during Q2 2024
  • For the 5-year period, Prenetics Global's Cost of Revenue averaged around $15.0 million, with its median value being $3.5 million (2023).
  • As far as peak fluctuations go, Prenetics Global's Cost of Revenue plummeted by 9568.95% in 2022, and later soared by 280251.4% in 2025.
  • Quarter analysis of 5 years shows Prenetics Global's Cost of Revenue stood at $41.0 million in 2021, then tumbled by 95.69% to $1.8 million in 2022, then surged by 56.26% to $2.8 million in 2023, then soared by 138.77% to $6.6 million in 2024, then skyrocketed by 44.72% to $9.5 million in 2025.
  • Its last three reported values are $9.5 million in Q3 2025, $10.4 million for Q2 2025, and $8.7 million during Q1 2025.